May 15, 2024
COPENHAGEN (Reuters) – Novo Nordisk does not expect a shortage of its Wegovy weight-loss drug in Denmark despite an earlier warning by the Danish Medicines Agency […]
May 15, 2024
The risk for moderate neutropenia associated with clozapine therapy is low in patients with treatment-resistant schizophrenia, and the risk for severe neutropenia is minimal, new research […]
May 15, 2024
BERLIN (Reuters) – Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-testing kit. Screening for […]
May 14, 2024
(Reuters) – Eli Lilly has entered into a settlement deal with a medi spa that had sold counterfeit versions of its popular diabetes drug Mounjaro and […]
May 14, 2024
Introduction This web page provides information related to upcoming new and revised product-specific guidances (PSGs) to support the development and approval of safe and effective generic […]
May 14, 2024
Generic medications are just as safe and effective as their brand-name counterparts, and often cost less. As 9 in 10 prescriptions filled are for generics, people […]
May 14, 2024
The results of a national multicenter study suggest that the diagnostic delay of celiac disease in the pediatric population is generally low in Italy and that […]
May 14, 2024
For Immediate Release: May 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, […]
May 14, 2024
VENICE, Italy — Four-year data from the SELECT cardiovascular outcomes trial show that the anti-obesity drug semaglutide (Wegovy) leads to clinically significant and durable weight loss […]